The CEO Roundtable on Cancer Salutes SAS and Meridian Health

The CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, salutes SAS Institute for being ranked No.1 on FORTUNE magazine’s annual “100 Best Companies to Work For” list.

SAS, under the leadership of founder and CEO, Jim Goodnight, was among the first companies in the nation to achieve CEO Cancer Gold Standard™ accreditation, recognizing the software company’s commitment to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle.

A long-time employer of choice, from its beginnings SAS has established a benefits plan and corporate culture that supports its belief that happy, healthy employees are more productive. Similarly, as a charter member of the CEO Roundtable on Cancer, Jim Goodnight has long recognized that employers have a unique opportunity to positively impact the health and well-being of employees and their families and in doing so, can also provide real hope in the fight against cancer.

The CEO Roundtable also wishes to congratulate Meridian Health, a health system based in New Jersey, on being named as one of the 100 best companies on FORTUNE’s list.   Meridian Health, under the leadership of President John Lloyd, joined the growing number of Gold Standard employers in 2009.  

Congratulations to both SAS and Meridian for achieving this distinction.



Return to News Articles...

GOLD STANDARD FOCUS

Read Dr. Leonard Berry’s powerful remarks to the CEO Roundtable on Cancer, September 11, 2009, Philadelphia, PA.
Employers of Choice Attacking Cancer



Learn how CEOs are making a difference in the lives of their employees by implementing the CEO Cancer Gold Standard.  Listen to what employees are saying about the Gold Standard in Their Own Voices.



Brochure.pngLearn much more about the Gold Standard by reading The Evidence and The Benefits to Your Organization

Did You Know?

Cancer is the second most common cause of death in the US, exceeded only by heart disease.